(Q38309488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Graham Packham

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Habens F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lapham AS

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dallman CL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pickering BM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Michels J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marcusson EG

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

18 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1910-1919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209979

30 December 2019

exact match

0 references

cites work

Identification of a human cDNA encoding a novel Bcl-x isoform.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

BCL-2 family: regulators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Regulation of Bcl-xL: a little bit of this and a little bit of STAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Ets proteins in biological control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

ETS transcription factors and their emerging roles in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

The function of the bcl-x promoter in erythroid progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Identification of a novel human BCL-X promoter and exon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Bcl-x(L) is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209979

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983335%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 December 2019

1017291785

0 references

1 reference